Abuse Liability of Pregabalin and Its Effects on Benzodiazepine Withdrawal Symptoms
Status:
Terminated
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if a single dose of pregabalin 300mg in patients
receiving medications for sedative-hypnotic withdrawal symptoms will produce meaningful
differences in measures of "drug liking" and "drug high" as compared to placebo.